Satsuma Pharmaceuticals Inc (STSA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.1000 -0.0100 (-0.90%) 06/07/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.1000 unch (unch) -
for Wed, Jun 7th, 2023
Results
download Want to compare other data? Select FieldsSymbol | STSA | FBRX | OKYO | ||
Company | Satsuma Pharmaceuticals Inc | Forte Biosciences Inc | Okyo Pharma Limited ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.1100 | 5.84 | 1.0400 | ||
High | 1.1400 | 5.84 | 1.0800 | ||
Low | 1.0100 | 5.28 | 1.0400 | ||
Last | 1.1000 | 5.26 | 1.0500 | ||
Change | -0.0100 | -0.30 | -0.0200 | ||
% Change | -0.90% | -5.40% | -1.87% | ||
Volume | 1,829,700 | 14,504 | 2,801 | ||
20-Day Average Volume | 576,695 | 53,390 | 64,168 | ||
Previous Close | 1.1100 | 5.56 | 1.0700 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 1.0658 | 6.80 | 1.2958 | ||
20-Day Raw Stochastic | 69.23% | 6.96% | 1.82% | ||
20-Day Relative Strength | 58.87% | 36.73% | 40.56% | ||
Weighted Alpha | -14.90 | -87.48 | -23.70 | ||
Today's Opinion | 8% Buy | 88% Sell | 8% Buy | ||
Previous Opinion | 8% Buy | 88% Sell | 8% Buy | ||
Last Month's Opinion | 8% Sell | 40% Sell | 72% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +4.76% since 05/31/23 | -27.62% since 04/02/25 | -16.80% since 04/02/25 | ||
Low | 1.0100 on 06/07/23 | 5.02 on 04/07/25 | 1.0300 on 04/08/25 | ||
High | 1.1400 on 06/07/23 | 7.13 on 04/03/25 | 1.2537 on 04/03/25 | ||
1-Month | |||||
%Chg | +2.80% since 05/05/23 | -18.15% since 03/07/25 | -27.27% since 03/07/25 | ||
Low | 1.0100 on 06/07/23 | 5.02 on 04/07/25 | 1.0300 on 04/08/25 | ||
High | 1.1400 on 06/07/23 | 9.33 on 03/24/25 | 1.5799 on 03/13/25 | ||
3-Month | |||||
%Chg | +16.17% since 03/07/23 | -72.63% since 01/08/25 | -19.07% since 01/08/25 | ||
Low | 0.6550 on 04/14/23 | 5.02 on 04/07/25 | 0.9016 on 01/30/25 | ||
High | 1.4700 on 04/17/23 | 20.50 on 01/10/25 | 1.5799 on 03/13/25 | ||
6-Month | |||||
%Chg | +31.28% since 12/07/22 | +6.40% since 10/09/24 | +0.98% since 10/09/24 | ||
Low | 0.6550 on 04/14/23 | 4.11 on 11/01/24 | 0.9016 on 01/30/25 | ||
High | 1.4700 on 04/17/23 | 28.68 on 12/06/24 | 1.5799 on 03/13/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 36,467 | 36,594 | 36,205 | ||
Shares Outstanding, K | 33,152 | 6,582 | 33,836 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -70,060,000 | -35,480,000 | -16,830,000 | ||
Last Quarter Sales | 0 | 0 | N/A | ||
Last Quarter Net Income | -10,290,000 | -7,160,000 | N/A | ||
60-Month Beta | 0.10 | 2.52 | -0.32 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.31 on 05/11/23 | -4.54 on 11/14/24 | N/A | ||
Latest Earnings Date | 05/16/23 | 05/12/25 | 08/20/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | 03/28/14 | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |